Related Experiment Videos
Clinical significance of protein C
1Department of Clinical Haematology, Teaching Hospital, Pekarská-Brno, CSSR.
Insights
Protein C levels significantly decrease in patients with disseminated intravascular coagulation (DIC), unlike those with myocardial infarction (MI) or healthy individuals. Monitoring protein C is crucial for managing DIC and preventing thromboembolic complications.
Area of Science:
- Biochemistry
- Hematology
- Medical Diagnostics
Background:
- Coagulation inhibitors are vital for maintaining hemostasis.
- Protein C is a key anticoagulant protein.
- Disseminated intravascular coagulation (DIC) and myocardial infarction (MI) are critical conditions involving hemostatic dysregulation.
Purpose of the Study:
- To investigate and compare protein C levels in patients with DIC and MI.
- To establish the diagnostic significance of protein C levels in these patient groups.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) and electroimmunoassay (EID) were employed for protein C quantification.
- Protein C levels were measured in three groups: patients with DIC, patients with MI, and healthy donors.
Main Results:
- A significant decrease in protein C levels was observed in patients with DIC compared to both MI patients and healthy donors.
- Protein C levels in MI patients were not significantly different from healthy donors.
Conclusions:
- Reduced protein C levels are indicative of DIC.
- Protein C deficiency necessitates treatment to mitigate thromboembolic risks.
- Assessing protein C levels aids in differentiating DIC from other conditions like MI.
Abstract:
The coagulation inhibitors are important components of control mechanisms which ensure the haemocoagulation equilibrium. One of them is protein C, whose level was followed in patients with DIC. and IM. In DIC. cases a significant decrease was noted with regard to the MI groups and healthy donors. EID and ELISA methods were used for testing. The patients exhibiting the protein C defect require a corresponding treatment which should suppress the thromboembolic complications.